Ka Lai Yee - Concepedia

Author

Ka Lai Yee

Merck & Co., Inc., Rahway, NJ, USA (United States)ORCID

Also Known As

David Rosenbaum, K. Yee, K.L. Yee, Ka Yee Ma, Ka L Yee, Ka L. Yee, Ka Lai Yee, Ka Yee, Yee, Ka Lai

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Celerion (United States)Medica (United States)United States Military Academy Orlando Clinical Research Center

About

Ka Lai Yee is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	330
2	Health Sciences	2	2	64
3	Engineering	1	1	32
4	Natural Sciences	1	1	43
5	Social Sciences	1	1	18

Ka Lai Yee

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Effects of Suvorexant, an Orexin Receptor Antagonist, on Sleep Parameters as Measured by Polysomnography in Healthy Men Hong Sun, William P. Kennedy, Darren Wilbraham, SLEEP	2013	158
The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold Anthony L. Gotter, Christopher J. Winrow, Joseph Brunner, BMC Neuroscience	2013	93
Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to Man Anthony L. Gotter, Mark S. Forman, C. Meacham Harrell, Scientific Reports	2016	78
Characterisation of the absorption, distribution, metabolism, excretion and mass balance of doravirine, a non-nucleoside reverse transcriptase inhibitor in humans Rosa I. Sánchez, Kerry L. Fillgrove, Ka Lai Yee, Xenobiotica	2018	56
A Microdose Cocktail to Evaluate Drug Interactions in Patients with Renal Impairment Daniel Tatosian, Ka Lai Yee, Zufei Zhang, Clinical Pharmacology & Therapeutics	2020	52
The Effect of Single and Multiple Doses of Rifampin on the Pharmacokinetics of Doravirine in Healthy Subjects Ka Lai Yee, Sauzanne Khalilieh, Rosa I. Sánchez, Clinical Drug Investigation Healthy SubjectsPharmacodynamicsMultiple DosesMedicinePharmacological Study	2017	46
Development of In Vitro–In Vivo Correlation for Amorphous Solid Dispersion Immediate-Release Suvorexant Tablets and Application to Clinically Relevant Dissolution Specifications and In-Process Controls Filippos Kesisoglou, Andre Hermans, Colleen M. Neu, Journal of Pharmaceutical Sciences Pharmaceutical ScienceExcipientsIn-process ControlsPharmaceutical TechnologyBiomedical Engineering	2015	44
Results of a Doravirine-Atorvastatin Drug-Drug Interaction Study Sauzanne Khalilieh, Ka Lai Yee, Rosa I. Sánchez, Antimicrobial Agents and Chemotherapy	2016	44
Effect of Different Durations of Ketoconazole Dosing on the Single‐Dose Pharmacokinetics of Midazolam: Shortening the Paradigm S. Aubrey Stoch, Evan Friedman, A. Maes, The Journal of Clinical Pharmacology Medicinal ChemistryCytochrome P450 3APharmacological StudyBiochemistryDifferent Durations	2009	43
A randomized, double-blind, placebo-controlled, short-term monotherapy study of doravirine in treatment-naive HIV-infected individuals Dirk Schürmann, Christian Sobotha, Jocelyn Gilmartin, AIDS	2015	43

Page 1